TY  - JOUR
AU  - Aomar-Millán, Ismael Francisco
AU  - Salvatierra, Juan
AU  - Torres-Parejo, Úrsula
AU  - Nuñez-Nuñez, María
AU  - Hernández-Quero, José
AU  - Anguita-Santos, Francisco
PY  - 2021
DO  - 10.1016/j.medcli.2021.01.006
UR  - http://hdl.handle.net/10668/17226
T2  - Medicina clinica
AB  - To assess clinical outcomes according to the immunosuppressive treatment administered to patients with severe SARS-CoV-2 pneumonia and moderate inflammation. A retrospective observational cohort study involving 142 patients with severe COVID-19...
LA  - en
KW  - COVID-19
KW  - Cytokine storm syndrome
KW  - Inflamación
KW  - Inflammation
KW  - Methylprednisolone
KW  - Metilprednisolona
KW  - Síndrome de tormenta de citoquinas
KW  - Tocilizumab
KW  - Antibodies, Monoclonal, Humanized
KW  - Glucocorticoids
KW  - Humans
KW  - Inflammation
KW  - Retrospective Studies
KW  - SARS-CoV-2
KW  - Treatment Outcome
KW  - COVID-19 Drug Treatment
TI  - Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation.
T2  - Glucocorticoides solos versus tocilizumab solo o glucocorticoides más tocilizumab en pacientes con neumonía grave por SARS-CoV-2 e inflamación moderada.
TY  - research article
VL  - 156
ER  -